64 related articles for article (PubMed ID: 2493336)
1. The action of oncogenes and growth factors in tumour initiation and promotion.
Akhurst R; Bailleul B; Brown K; Ramsden M; Fee F; Balmain A
Carcinog Compr Surv; 1989; 11():243-55. PubMed ID: 2493336
[No Abstract] [Full Text] [Related]
2. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.
Quintanilla M; Brown K; Ramsden M; Balmain A
Nature; 1986 Jul 3-9; 322(6074):78-80. PubMed ID: 3014349
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
4. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
[TBL] [Abstract][Full Text] [Related]
5. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
6. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
Jhappan C; Takayama H; Dickson RB; Merlino G
Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
[TBL] [Abstract][Full Text] [Related]
10. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.
Strickland JE; Greenhalgh DA; Koceva-Chyla A; Hennings H; Restrepo C; Balaschak M; Yuspa SH
Cancer Res; 1988 Jan; 48(1):165-9. PubMed ID: 3121168
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
12. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
13. Investigations of multistage carcinogenesis: applications of in vitro-in vivo studies.
O'Connell JF; Miller DR; Morris RJ; Patskan GP; Viaje AV; Tacker K; Slaga TJ
Carcinog Compr Surv; 1989; 11():339-48. PubMed ID: 2493337
[No Abstract] [Full Text] [Related]
14. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
15. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.
Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T
Cancer Res; 2004 Dec; 64(24):8808-10. PubMed ID: 15604236
[TBL] [Abstract][Full Text] [Related]
16. Stages of tumour promotion in skin.
Marks F; Fürstenberger G
IARC Sci Publ; 1984; (56):13-22. PubMed ID: 6443102
[No Abstract] [Full Text] [Related]
17. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.
Song S; Liem A; Miller JA; Lambert PF
Virology; 2000 Feb; 267(2):141-50. PubMed ID: 10662610
[TBL] [Abstract][Full Text] [Related]
18. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas.
Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y
Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021
[TBL] [Abstract][Full Text] [Related]
19. Role of oncogene activation during prenatal (transplacental) initiation and postnatal promotion of mouse skin tumours.
Yamasaki H; Hollstein M; Cabral JR; Tomatis L
IARC Sci Publ; 1989; (96):221-37. PubMed ID: 2680947
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
